BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3795615)

  • 1. Effects of cholecystokinin tetra and octa peptides on locomotor activity in mice.
    Takeda Y; Takano Y; Kamiya H
    Jpn J Pharmacol; 1986 Sep; 42(1):145-9. PubMed ID: 3795615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered responding to cholecystokinins and dopaminergic agonists following 6-hydroxydopamine treatment in rats.
    Hsiao S; Katsuura G; Itoh S
    Behav Neurosci; 1985 Oct; 99(5):853-60. PubMed ID: 3939625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of nucleus accumbens to activities related to cholecystokinins in rats.
    Katsuura G; Itoh S; Hsiao S
    Peptides; 1985; 6(1):91-6. PubMed ID: 3991366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cholecystokinin-related peptides on retention of passive avoidance behaviour.
    Fekete M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1982; 60(4):237-42. PubMed ID: 6314742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C-terminal tetrapeptide of cholecystokinin decreases hunger in rats.
    Halmy L; Nyakas C; Walter J
    Experientia; 1982 Jul; 38(7):873-4. PubMed ID: 7106265
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of tetra- and octapeptide of cholecystokinin on exocrine and endocrine secretions in the isolated perfused rat pancreas].
    Otsuki M; Ohki A; Okabayashi Y; Sakamoto C; Suehiro I; Baba S
    Nihon Shokakibyo Gakkai Zasshi; 1984 Mar; 81(3):907-11. PubMed ID: 6205182
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholecystokinin peptides in vitro modulate the characteristics of the striatal 3H-N-propylnorapomorphine sites.
    Agnati LF; Celani MF; Fuxe K
    Acta Physiol Scand; 1983 May; 118(1):79-81. PubMed ID: 6312748
    [No Abstract]   [Full Text] [Related]  

  • 8. Antinociceptive action of cholecystokinin octapeptide (CCK 8) and related peptides in rats and mice: effects of naloxone and peptidase inhibitors.
    Hill RG; Hughes J; Pittaway KM
    Neuropharmacology; 1987 Apr; 26(4):289-300. PubMed ID: 3295578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of cholecystokinin and its related peptides in rats.
    Itoh S; Katsuura G
    Prog Clin Biol Res; 1985; 192():139-45. PubMed ID: 2934743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive avoidance deficit following intracerebroventricular administration of cholecystokinin tetrapeptide amide in rats.
    Katsuura G; Itoh S
    Peptides; 1986; 7(5):809-14. PubMed ID: 3797342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of cholecystokinin-octapeptide and tetragastrin on the contractile activities of the stomach, duodenum and papilla of Vater].
    Yada S; Komi N
    Nihon Heikatsukin Gakkai Zasshi; 1988 May; 24(2):101-11. PubMed ID: 3244211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity.
    Soar J; Hewson G; Leighton GE; Hill RG; Hughes J
    Pharmacol Biochem Behav; 1989 Jul; 33(3):637-40. PubMed ID: 2587606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCK4 contains the full hormonal information of cholecystokinin in isolated pancreatic acini.
    Sankaran H; Bailey AC; Willaims JA
    Biochem Biophys Res Commun; 1981 Dec; 103(4):1356-62. PubMed ID: 6174128
    [No Abstract]   [Full Text] [Related]  

  • 14. Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokinin.
    Khosla S; Crawley JN
    Life Sci; 1988; 42(2):153-9. PubMed ID: 3336275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety.
    Rex A; Barth T; Voigt JP; Domeney AM; Fink H
    Neurosci Lett; 1994 May; 172(1-2):139-42. PubMed ID: 8084519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A behavioural pharmacological study on intracerebroventricularly administered CCK-8 related peptides in mice.
    Hagino Y; Moroji T; Iizuka R
    Neuropeptides; 1989; 13(2):107-13. PubMed ID: 2739882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of A71623, a highly selective CCK-A agonist tetrapeptide.
    Asin KE; Bednarz L; Nikkel AL; Gore PA; Montana WE; Cullen MJ; Shiosaki K; Craig R; Nadzan AM
    Am J Physiol; 1992 Jul; 263(1 Pt 2):R125-35. PubMed ID: 1636779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversed behavioral effect of cholecystokinin after frontal decortication in rats.
    Itoh S; Katsuura G; Itoh T; Morimoto T
    Life Sci; 1994; 55(11):PL213-6. PubMed ID: 8072383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sulfated cholecystokinin octapeptide and cholecystokinin tetrapeptide in rat behavior after blockade of nitric oxide synthase by L-NAME.
    Hoły Z; Wiśniewski K
    Rocz Akad Med Bialymst; 1998; 43():250-70. PubMed ID: 9972062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A behavioral pharmacological study on CCK-8 related peptides in mice.
    Moroji T; Hagino Y
    Neuropeptides; 1986 Oct; 8(3):273-86. PubMed ID: 3785587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.